DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a tradable short squeeze develop as the bears rush to cover their positions to avoid big losses. Even the best short-sellers know that it's never a great idea to stay short once a bullish earnings report sparks a big short-covering rally.
>>5 Stocks Ready to Break Out
This is why I scan the market for heavily shorted stocks that are about to report earnings. You only need to find a few of these stocks in a year to help enhance your portfolio returns -- the gains become so outsized in such a short time frame that your profits add up quickly.
That said, let's not forget that stocks are heavily shorted for a reason, so you have to use trading discipline and sound money management when playing earnings short-squeeze candidates. It's important that you don't go betting the farm on these plays and that you manage your risk accordingly. Sometimes the best play is to wait for the stock to break out following the report before you jump in to profit off a short squeeze. This way, you're letting the trend emerge after the market has digested all of the news.
5 Best New Stocks To Watch For 2015: Nanometrics Incorporated(NANO)
Nanometrics Incorporated provides high-performance process control metrology systems used primarily in the fabrication of integrated circuits, high-brightness LEDs, data storage devices, and solar photovoltaics. It offers automated metrology systems that provide optical critical dimension, thin film metrology, and wafer stress for transistor and interconnect metrology applications; the Lynx cluster metrology platform for use in wafer metrology applications, including optical critical dimension, overlay, and thin film process control; and integrated metrology systems, which provide near real-time measurements. The company's automated and integrated systems are also used in various process control applications, including dimension and film thickness measurement, device topography, and defect inspection, as well as used in the analysis of other film properties, such as optical, electrical, and material characteristics. Its process control solutions are deployed in the fabrica tion process from front-end-of-line substrate manufacturing to high-volume production of semiconductors and other devices, and to wafer-scale packaging applications. The company sells its metrology and inspection systems directly and through original equipment manufacturer channels to semiconductor manufacturers and equipment suppliers, and producers of high-brightness-LEDs, solar photovoltaics, data storage devices, silicon wafers, and photomasks worldwide. Nanometrics Incorporated was founded in 1975 and is headquartered in Milpitas, California.
Advisors' Opinion:- [By Steve Symington]
What:�Shares of Nanometrics Incorporated� (NASDAQ: NANO ) �popped more than 10% during Wednesday's intraday trading, then settled to close up 7% after the company turned in better-than-expected fourth quarter earnings.�
Top 5 Industrial Disributor Stocks To Invest In 2014: Carnival Corporation(CCL)
Carnival Corporation operates as a cruise and vacation company. It provides cruises to various vacation destinations with a portfolio of cruise brands comprising Carnival Cruise Lines, Holland America Line, Princess Cruises, and Seabourn in North America; and AIDA Cruises, Costa Cruises, Cunard, Ibero Cruises, and P&O Cruises in Europe, Australia, and Asia. The company also involves in operation of hotels, as well as offers tour and transportation services. It operates approximately 98 ships, as well as owns and operates 15 hotels or lodges that include 3,420 guest rooms; 395 motorcoaches; and 20 domed rail cars. The company sells its cruises through travel agents, including wholesalers and tour operators. Carnival Corporation was founded in 1974 and is headquartered in Miami, Florida.
Advisors' Opinion:- [By Garrett Cook]
Carnival (NYSE: CCL) reported better-than-expected fiscal third-quarter earnings and raised its FY14 forecast.
The Miami, Florida-based company posted a quarterly fiscal third-quarter profit of $1.25 billion, or $1.60 per share, versus a year-ago profit of $934 million, or $1.20 per share.
- [By Shauna O'Brien]
Before Friday’s opening bell, Carnival Corporation (CCL) released its fourth quarter earnings. The cruise ship company reported a net loss, but beat analysts’ expectations.�
CCL’s Earnings in Brief
CCL posted a net loss of $102, or 13 cents per share, compared to net income of $66 million, or 8 cents per share, a year ago. Adjusted earnings were $210 million, or 27 cents per share, up from $35 million, or 4 cents per share, last year. Revenue increased to $3.72 billion from $3.66 billion. On average, analysts expected to see adjusted earnings of 20 cents and $3.81 billion in revenue. Looking ahead, the company expects to see FY2015 non-GAAP earnings between $2.30 and $2.60 per share. Analysts expect to see EPS of $2.34.CEO Commentary
Carnival Corporation & plc President and CEO�Arnold Donald commented:�“Full year earnings were significantly higher than the prior year primarily due to strong profit improvement at both our Carnival Cruise Lines and Costa Cruises brands. We enjoyed some early wins from our collaboration efforts that contributed to our improved results, particularly for onboard revenues. We worked hard to contain costs and achieved an almost five percent reduction in fuel consumption for the year as we continue to implement energy conservation measures. We also made a number of strategic decisions in fleet investments that will position us well for the future.”
CCL’s Dividend
CCL paid its last 25 cent dividend on November 21. We expect the company to declare its next dividend in January.
CCL Dividend SnapshotAs of market close on December 18, 2014
Click here to see the complete history of CCL dividends.
Carnival shares were down 37 cents, or 0.87%, during Friday morning trading. The stock is up 9.73% YTD.
Top 5 Industrial Disributor Stocks To Invest In 2014: CBIZ Inc (CBZ)
CBIZ, Inc. (CBIZ) provides professional business services, products and solutions. These services are provided to businesses of various sizes, as well as individuals, governmental entities and not-for-profit enterprises throughout the United States and parts of Canada. CBIZ delivers its services through four practice groups: Financial Services, Employee Services, and National Practices. Its Financial Services group includes accounting, tax, financial advisory, valuation, litigation support, internal audit, family office services, fraud detection and real estate advisory. Its Employee Services group provides group health, property and casualty, retirement planning, payroll services, life insurance, human capital management, compensation consulting, recruiting and actuarial services. MMP group includes coding and billing, accounts receivable management and full practice management services. National Practices group includes managed networking and hardware services, health care consulting, and mergers and acquisitions. Effective July 1, 2012, the Company acquired the assets of Stoltz and Company, LTD., L.L.P. In October 2012, it acquired the assets of ProMedical, Inc. On December 31, 2012, the Company acquired the non-attest assets of PHBV Partners, L.L.P. Effective May 1, 2013, it announced that it has acquired Associated Insurance Agents. In September 2013, CBIZ, Inc completed the sale of its Medical Management Professionals (MMP) business to Zotec Partners, LLC.
On January 1, 2011, CBIZ sold its individual wealth management business. Effective November 1, 2011, the Company acquired the defined benefit actuarial consulting practice of PSA Insurance and Financial Services of Hunt Valley, Maryland. During the year ended December 31, 2011, CBIZ acquired four businesses: Thompson Dunavant PLC, Gresham Smith LLC, Multiple Benefit Services, Inc. and Atlantic MDR, LLC (d/b/a Advantage Benefit Planning). On January 1, 2012, the Company acquired Meridian Insurance Group, LLC.
Financial! Services
The Financial Services practice is divided into a Financial Services division, representing the United States, and a National Services division consisting of those units that provide their services nationwide. CBIZ and its subsidiaries maintain joint-referral relationships and administrative service agreements (ASAs) with independent licensed Certified Public Accounting (CPA) firms under which audit and attest services may be provided to CBIZ�� clients by such CPA firms. Under these ASAs, CBIZ provides a range of services to the CPA firms, including (but not limited to) administrative functions, such as office management, bookkeeping, and accounting, preparing marketing and promotion materials, providing office space, computer equipment, and systems support, and leasing administrative and professional staff. As of December 31, 2011, CBIZ maintained ASAs with four CPA firms.
Employee Services
The business units that comprise CBIZ�� Employee Services group are organized between Retail and National Services. The Retail offices provide services within their geographic area. The National group includes a number of specialty operations that provide services on a national scale. CBIZ�� Employee Services group maintains relationships with different insurance carriers. Some of these carriers have compensation arrangements.
National Practices
The National Practices group offers technology, health care consulting, and merger and acquisition services. The units within the National Practices group each have a Business Unit President.
Advisors' Opinion:- [By Seth Jayson]
CBIZ (NYSE: CBZ ) reported earnings on July 29. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), CBIZ whiffed on revenues and missed estimates on earnings per share.
Top 5 Industrial Disributor Stocks To Invest In 2014: Endo Pharmaceuticals Holdings Inc. (ENDP)
Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. The company�s Endo Pharmaceuticals segment offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel for pain, urology, endocrinology, and oncology. Its Qualitest segment provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women�s health, and hypertension markets. The company�s AMS segment offers various technology solutions comprising AMS 700 MS series, AMS 800 artificial urinary sphincter, GreenLight XPS laser system, Elevate transvaginal pelvic floor repair system, and Monarc subfascial hammock products in the areas of men�s and women�s health, and BPH therapy. Its HealthTronics segment provides urological services, such as lithotripsy, prostate treatment, anatomical pathology, and electron ic medical record services to urologists, hospitals, surgery centers, and clinics; and manufactures, sells, and maintains medical devices for tissue and tumor ablation. The company�s products under development primarily include Aveed, an injectable testosterone preparation to treat male hypogonadism; BEMA Buprenorphine, a transmucosal form of buprenorphine in Phase III trials for treating moderate to severe chronic pain; ODM-201, an androgen receptor antagonist in Phase II clinical testing to treat castrate resistant prostate cancer; and EN3342, a polyurethane implant in Phase I/II trials for the maintenance treatment of schizophrenia in adults. It serves pharmacy chains directly; and hospitals, governmental agencies, pharmacies, and physicians through wholesale drug distributors. The company was formerly known as Endo Pharmaceuticals Holdings Inc. and changed its name to Endo Health Solutions Inc. in May 2012. Endo Health Solutions Inc. was founded in 1997 and is headquart ered in Malvern, Pennsylvania.
Advisors' Opinion:- [By Ben Levisohn]
Shares of Endo International (ENDP) jumped out of the gate after Morgan Stanley upgraded the stock this morning. Since then, its shares have given back those gains and turned negative.
Morgan Stanley’s Christopher Caponetti and David Risinger explain why they upgraded Endo to Overweight from Equal-Weight:
Mesh settlement removes what had been a potential multi-billion dollar liability in our bear case, and we now see a compelling risk-reward driven by M&A upside in our bull case…
Endo�� current base business offers support, and we see limited downside in our bear case. We envision a bull case driven by dramatic value creation from M&A, and we est. Endo has $2-$3B of balance sheet flexibility (net of anticipated after-tax mesh cash outflows) to pursue M&A if mgmt. takes leverage from 3.0x to 4.0-4.25x (inc. mesh)…Mgmt�� stated objective is to complete ��t least 2-3 near-term accretive, valuecreating transactions��in the $250M-$500M range.
While noting that they have no information, Caponetti and Risinger explain that the “non-core assets of Major Pharma companies can move the needle for $10B market cap Endo.” And there are plenty of those up for sale, they note. Merck (MRK) is looking to sell a $15 billion drug portfolio, while Sanofi (SNY) is exploring a $7 billion sale, as well.
Shares of Endo were up 2.4% at the open but have fallen 0.1% to $66.27 as of 1:57 p.m. Merck has dropped 2.4% to $58.20 and Sanofi has declined 0.6% to $54.07.
- [By Rich Smith]
Malvern, Pa.-based Endo Health Solutions (NASDAQ: ENDP ) is looking for a new CFO.
On Wednesday, Endo announced that Executive Vice President and Chief Financial Officer Alan G. Levin will soon be leaving the company after a four-year stint to spend more time on "corporate board service and philanthropy, while traveling and spending more time with [his] family."
No comments:
Post a Comment